Sunitinib followed by sorafenib or vice versa for metastatic renal cell carcinoma—data from the Czech registry

Autor: Buchler, T. ^*, Klapka, R., Melichar, B., Brabec, P., Dušek, L., Vyzula, R., Abrahamova, J.

Publikováno v: In Annals of Oncology February 2012 23(2):395-401

Autofluorescence (safe) bronchoscopy and p21/ki-67 immunostaining related to carcinogenesis

Autor: Horvath, T.A, Hirano, T, Horvathova, M.D, Vomela, J, Vyzula, R, Čı́halová, M, Dorociak, F, Ebihara, Y, Furukawa, K, Habanec, B, Ikeda, N, Kakihana, M, Klusáková, J, Okada, S, Rejthar, A, Stratil, D, Shaffi-Sahely, A, Šmajer, B, Špelda, S, Tsuboi, M, Vagunda, V, Wurst, F, Kato, H

Publikováno v: In Photodiagnosis and Photodynamic Therapy 2004 1(1):13-22

[Can we Observe Ethnic Difference in Basic Blood Tests? Single-institution Data from Cancer Prevention Programme in the Czech Republic]

Autor: Řiháček M, Valík D, Vyzula R, Lenka Zdrazilova-Dubska

Publikováno v: Europe PubMed Central

Laboratory tests are standard part of a routine check-up of current medical status and an important tool in diagnostic workup, in planning or evaluation of treatment, and disease monitoring. To reduce misdiagnosis, accurate reference intervals reflec

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::f1a507e894c0017a2974a30fc6526770
https://pubmed.ncbi.nlm.nih.gov/28471198

Adjuvant Sunitinib in High-Risk Renal-Cell Carcinoma after Nephrectomy

Autor: Ravaud, A, Motzer, Rj, Pandha, Hs, George, Dj, Pantuck, Aj, Patel, A, Chang, Yh, Escudier, B, Donskov, F, Magheli, A, Carteni, G, Laguerre, B, Tomczak, P, Breza, J, Gerletti, P, Lechuga, M1, Lin, X, Martini, Jf, Ramaswamy, K, Casey, M, Staehler, M, Patard, Jj, Gruenwald, V, Link, K, Doehn, C, Heinzer, H, Grimm, M-O, Wirth, M, Stoeckle, M, Heidenreich, A, Garcia del Muro Solans, X, Mellado, Bo, Castellano, Dg, Frydenberg, M, Schobinger, Sr, Dimopoulos, Ma, Rothermundt, C, Climent Duran MA, Melotti, B, Procopio, G, Boccardo, F, Sella, A, Stewart, S, Adenis, A, Jones, Rj, Chevreau, C, Prausova, J, Vyzula, R, Oudard, S, Jacqmin, D, Gravis, G, Varela, R, Herrmann, E, Lim, Hy, Lee, J-L, Kim, Yh, Kim, Jh, Y-C, Ou, Papakotoulas, P, Iacobelli, S, Chowdhury, S, Passalacqua, R, Tomasek, J, Anton Aparicio LM, Linassier, C, Hauser, S, Bergmann, L, Hawkins, Re, Szczylik, C, Zdrojowy, R, Sosnowski, M, Koralewski, P, Wiechnio, Pj, Schraml, J, Mardiak, J, Laurinc, P, Kliment, J, Rosenbaum, E, Lundstam, S, Flodgren, P, Ljungberg, B, Stenzl, A, Schnoeller, Tj, Mcdermott, Sr, Breathnach, Os, Mccaffrey, Ja, Donnellan, P, The, G-C, Rolland, F, Brekkan, E, Nilsson, C, Kim, Wy, Bishoff, J, Chung, J, Shore, Nd, Master, V, Tang Chen DY, Ye, D, Huang, Y, Jin, J, Song, B, Zhou, F, Galceran, Jc, Yao, X, Zhang, X.

Publikováno v: Ravaud, A, Motzer, R J, Pandha, H S, George, D J, Pantuck, A J, Patel, A, Chang, Y-H, Escudier, B, Donskov, F, Magheli, A, Carteni, G, Laguerre, B, Tomczak, P, Gerletti, P, Lechuga, M, Lin, X, Martini, J-F, Ramaswamy, K, Casey, M, Staehler, M, Patard, J-J & S-TRAC Investigators 2016, ' Adjuvant Sunitinib in High-Risk Renal-Cell Carcinoma after Nephrectomy ', The New England Journal of Medicine, vol. 375, no. 23, pp. 2246-2254 . https://doi.org/10.1056/NEJMoa1611406

BACKGROUNDSunitinib, a vascular endothelial growth factor pathway inhibitor, is an effectivetreatment for metastatic renal-cell carcinoma. We sought to determine the efficacyand safety of sunitinib in patients with locoregional renal-cell carcinoma a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::044148e0163ba78bfbd9d2be3de578c8
https://surrey.eprints-hosting.org/812586/

Prevalence symptomů úzkosti a deprese a jejich vliv na kvalitu života u pacientů v paliativní onkologické léčbě - projekt PALINT. (Czech)

Autor: Světláková, L., Sláma, O., Světlák, M., Pochop, L., Šedo, J., Alexandrová, R., Bílek, O., Vyzula, R.

Publikováno v: Journal of the Czech & Slovak Societies for Oncology / Klinická Onkologie; 2019, Vol. 32 Issue 3, p201-207, 7p